ELANE and ovarian cancer: To further investigate the expression of NE and β-catenin in ovarian cancer and analyze their clinicopathological significance, the expression levels of NE and β-catenin were assayed in 17 ovarian cysts, 38 serous carcinomas, 14 mucous carcinomas, and 19 other pathological subtypes of ovarian cancer by tumor tissue arrays (Table 1).